Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse

NCT00189553 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

976

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Fallopian Tube Cancer

Interventions

DRUG: Pegylated liposomal doxorubicin
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

ARCAGY/ GINECO GROUP

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]